Author Guidelines

Submit Now Publication Process Download Mendeley Desktop

Thank you for considering AHPROCE for your work. Please follow these guidelines to ensure a smooth submission and review process.

• Original Articles — full reports of primary research.
• Review Articles — systematic/scoping or narrative reviews with clear methodology.
• Short Communications — brief novel findings, methods, or negative results.
• Case Studies/Practice Notes — real-world implementations, program evaluations.
• Protocol Papers — detailed study/implementation protocols (registered when applicable).
• Perspectives/Commentaries — policy/practice insights grounded in evidence.

• Language: clear academic English.
• File: Word (.doc/.docx). Supplementary files allowed (CSV, ZIP, PDF, images).
• Font & Spacing: Times New Roman 12 pt, double-spaced, 1-inch (2.54 cm) margins.
• Title Length: max 15 words.
• Total Length: ≤ 8,000 words (includes abstract, main text, references, captions, tables).
• Referencing: APA 7th (author–date). e.g., (Smith & Lee, 2023).
• File Naming: AHPROCE_FirstAuthor_ShortTitle_v1.docx.
• Anonymization: remove author identifiers from the blinded manuscript.

1. Title Page (separate): title (≤ 15 words), authors, affiliations, corresponding email, ORCID(s), funding, conflicts, acknowledgments, CRediT roles.
2. Abstract (≤ 250 words): background, objective, methods, results, conclusion; 3–6 keywords.
3. Main Text:
   • Introduction (≤ 850 words): phenomenon & issue; supporting theory; urgency & novelty; gaps in prior studies; end with objectives. Avoid explicit object/location/type; stress global benefit.
   • Methods: design; setting/participants; outcomes & measures; analysis; ethics/IRB; registrations.
   • Results: primary/secondary outcomes; tables/figures; effect sizes & 95% CI where relevant.
   • Discussion: interpretation; strengths/limitations; policy/practice implications; future work.
   • Conclusion: concise contribution to health promotion.
4. References: APA 7; include DOIs where available (use Mendeley).
5. Figures & Tables: with titles/legends, cited in order.
6. Supplementary: instruments, extended analyses, datasets (as permitted).

• CONSORT for randomized trials (incl. flow diagram; cluster/pragmatic extensions as appropriate).
• PRISMA for systematic reviews (search strategy, flowchart, risk of bias).
• STROBE for observational studies (cohort, case-control, cross-sectional).
• SQUIRE for implementation/quality improvement.

• Figures: ≥300 dpi (PNG/TIFF/JPEG; or SVG/EPS). Prefer separate files.
• Tables: editable (not images); no duplication.
• Units: SI units consistently.
• Abbreviations: define at first use; avoid in title/abstract when possible.

• Aligned with COPE/ICMJE/WAME.
• For human research: state IRB/ethics approval (ID) and informed consent.
• Clinical trials: prospective registration (e.g., ClinicalTrials.gov, WHO ICTRP).
• Privacy: de-identify data; permissions for identifiable images/quotes.
• Misconduct: plagiarism, fabrication/falsification, duplicate submission/publication are prohibited.
• AI tools: disclose tool/version/scope; authors remain responsible.

• CRediT roles for each author (Conceptualization, Methodology, Data Curation, Formal Analysis, Writing—Original Draft, Writing—Review & Editing, Supervision, Funding Acquisition).
• Authorship criteria: substantial contributions, drafting/revising, final approval, accountability.
• Conflicts of Interest: declare all; if none, state it.
• Funding: sponsors, grant numbers, and sponsor role.
• Acknowledgments for non-author contributors (with permission).

• Double-blind review: typically two independent reviewers; more if needed.
• Indicative timeline: screening 5–10 working days → peer review 3–6 weeks → decision/revisions as required.
• Appeals/Complaints: email admin@analysisdata.co.id with manuscript ID, rationale, and evidence.
• Corrections/Retractions follow COPE flowcharts.
• Decisions are evidence-based and independent of commercial influence.

Step-by-step publication process: https://analysisdata.co.id/index.php/AHPROCE/PublicationProcess

• Data availability: repository/DOI or justified restrictions (privacy, legal, ethical) and access conditions.
• Code: share when feasible (GitHub/OSF/Zenodo) with versioning and license.
• Preprints: allowed; include preprint DOI and update upon publication.
• Mendeley Desktop: manage library & insert APA 7 citations automatically in Word (Windows download link above).

• Full Name & Academic Title (lecturer/student).
• Email (active).
• Affiliation (department/faculty, institution, city, country).
• ORCID iD — register at https://orcid.org/ (required for corresponding author).
• Google Scholar ID — register with campus/student email: https://scholar.google.com/.
• Scopus Author ID (if any).

1. Prepare files: blinded manuscript; title page; figures (separate if applicable); supplementary files; reporting checklists (CONSORT/PRISMA/STROBE).
2. Submit: via OJS: https://analysisdata.co.id/index.php/AHPROCE/about/submissions.
3. Cover letter: rationale, novelty, fit to scope; disclose preprints/overlap.
4. After submission: track in OJS; respond to editor/reviewer comments on time.

Support: admin@analysisdata.co.id

1. Full Article (Word): complete manuscript (.doc/.docx), blinded.
2. Cover Letter + Author Profiles & Signatures: signed by all authors; include names, titles, emails, affiliations, ORCID, Scholar ID, Scopus ID (if any).
3. Turnitin Report (PDF): similarity ≤ 15%.

• Open Access: immediate and free to all readers.
• License: recommended CC BY 4.0; authors retain copyright.
• APC (“FREE Merdeka”): no submission/APC/publication fees for Indonesian-affiliated authors.
• Waivers/discounts available upon justified request for others.